
PubMed:11278581
Annnotations
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1012-1023 | Glycan_Motif | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT |
T2 | 1226-1237 | Glycan_Motif | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-143 | Sentence | denotes | Characterization of binding properties of urinary trypsin inhibitor to cell-associated binding sites on human chondrosarcoma cell line HCS-2/8. |
T2 | 144-383 | Sentence | denotes | Urinary trypsin inhibitor (UTI) forms membrane complexes with UTI-binding proteins (UTI-BPs) and initiates modulation of urokinase-type plasminogen activator (uPA) expression, which results in UTI-mediated suppression of cell invasiveness. |
T3 | 384-731 | Sentence | denotes | It has been established that suppression of uPA expression and invasiveness by UTI is mediated through inhibition of protein kinase C-dependent signaling pathways and that human chondrosarcoma cell line HCS-2/8 expresses two types of UTI-BPs; a 40-kDa UTI-BP (UTI-BP(40)), which is identical to link protein (LP), and a 45-kDa UTI-BP (UTI-BP(45)). |
T4 | 732-810 | Sentence | denotes | Here we characterize binding properties of UTI-BPs.UTI complexes in the cells. |
T5 | 811-957 | Sentence | denotes | In vitro ligand blot, cell binding and competition assays, and Scatchard analyses demonstrate that both UTI-BP(40) and UTI-BP(45) bind (125)I-UTI. |
T6 | 958-1086 | Sentence | denotes | A deglycosylated form of UTI (NG-UTI), from which the chondroitin-sulfate side chain has been removed, binds only to UTI-BP(40). |
T7 | 1087-1306 | Sentence | denotes | Additional experiments, using various reagents to block binding of (125)I-UTI and NG-UTI to the UTI-BP(40) and UTI-BP(45) confirm that the chondroitin sulfate side chain of UTI is required for its binding to UTI-BP(45). |
T8 | 1307-1497 | Sentence | denotes | Analysis of binding of (125)I-UTI and NG-UTI to the cells suggests that low affinity binding sites are the UTI-BP(40) (which can bind NG-UTI), and the high affinity sites are the UTI-BP(45). |
T9 | 1498-1682 | Sentence | denotes | In addition, UTI-induced suppression of phorbol ester stimulated up-regulation of uPA is inhibited by reagents that were shown to prevent binding of UTI to the 40- and 45-kDa proteins. |
T10 | 1683-1767 | Sentence | denotes | We conclude that UTI must bind to both of the UTI-BPs to suppress uPA up-regulation. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1012-1023 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
T2 | 1226-1237 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1012-1023 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
T2 | 1226-1237 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 110-124 | Phenotype | denotes | chondrosarcoma | HP:0006765 |
T2 | 562-576 | Phenotype | denotes | chondrosarcoma | HP:0006765 |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 110-124 | Disease | denotes | chondrosarcoma | http://purl.obolibrary.org/obo/MONDO_0008977 |
T2 | 135-138 | Disease | denotes | HCS | http://purl.obolibrary.org/obo/MONDO_0011669 |
T3 | 171-174 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T4 | 206-209 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T5 | 228-231 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T6 | 303-306 | Disease | denotes | uPA | http://purl.obolibrary.org/obo/MONDO_0004041 |
T7 | 337-340 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T8 | 428-431 | Disease | denotes | uPA | http://purl.obolibrary.org/obo/MONDO_0004041 |
T9 | 463-466 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T10 | 562-576 | Disease | denotes | chondrosarcoma | http://purl.obolibrary.org/obo/MONDO_0008977 |
T11 | 587-590 | Disease | denotes | HCS | http://purl.obolibrary.org/obo/MONDO_0011669 |
T12 | 618-621 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T13 | 636-639 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T14 | 644-647 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T15 | 711-714 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T16 | 719-722 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T17 | 775-778 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T18 | 915-918 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T19 | 930-933 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T20 | 953-956 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T21 | 983-986 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T22 | 991-994 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T23 | 1075-1078 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T24 | 1161-1164 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T25 | 1172-1175 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T26 | 1183-1186 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T27 | 1198-1201 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T28 | 1260-1263 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T29 | 1295-1298 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T30 | 1337-1340 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T31 | 1348-1351 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T32 | 1414-1417 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T33 | 1444-1447 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T34 | 1486-1489 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T35 | 1511-1514 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T36 | 1580-1583 | Disease | denotes | uPA | http://purl.obolibrary.org/obo/MONDO_0004041 |
T37 | 1647-1650 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T38 | 1700-1703 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T39 | 1729-1732 | Disease | denotes | UTI | http://purl.obolibrary.org/obo/MONDO_0005247 |
T40 | 1749-1752 | Disease | denotes | uPA | http://purl.obolibrary.org/obo/MONDO_0004041 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1012-1023 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
T2 | 1226-1237 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 1012-1023 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
T2 | 1226-1237 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 110-124 | Phenotype | denotes | chondrosarcoma | HP:0006765 |
T2 | 562-576 | Phenotype | denotes | chondrosarcoma | HP:0006765 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 104-109 | OrganismTaxon | denotes | human | 9606 |
T2 | 556-561 | OrganismTaxon | denotes | human | 9606 |
GlyCosmos15-CL
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 135-138 | Cell | denotes | HCS | http://purl.obolibrary.org/obo/CL:0000745 |
T2 | 232-235 | Cell | denotes | BPs | http://purl.obolibrary.org/obo/CL:0000748 |
T3 | 587-590 | Cell | denotes | HCS | http://purl.obolibrary.org/obo/CL:0000745 |
T4 | 622-625 | Cell | denotes | BPs | http://purl.obolibrary.org/obo/CL:0000748 |
T5 | 1733-1736 | Cell | denotes | BPs | http://purl.obolibrary.org/obo/CL:0000748 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 182-190 | Body_part | denotes | membrane | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-143 | Sentence | denotes | Characterization of binding properties of urinary trypsin inhibitor to cell-associated binding sites on human chondrosarcoma cell line HCS-2/8. |
T2 | 144-383 | Sentence | denotes | Urinary trypsin inhibitor (UTI) forms membrane complexes with UTI-binding proteins (UTI-BPs) and initiates modulation of urokinase-type plasminogen activator (uPA) expression, which results in UTI-mediated suppression of cell invasiveness. |
T3 | 384-731 | Sentence | denotes | It has been established that suppression of uPA expression and invasiveness by UTI is mediated through inhibition of protein kinase C-dependent signaling pathways and that human chondrosarcoma cell line HCS-2/8 expresses two types of UTI-BPs; a 40-kDa UTI-BP (UTI-BP(40)), which is identical to link protein (LP), and a 45-kDa UTI-BP (UTI-BP(45)). |
T4 | 732-810 | Sentence | denotes | Here we characterize binding properties of UTI-BPs.UTI complexes in the cells. |
T5 | 811-957 | Sentence | denotes | In vitro ligand blot, cell binding and competition assays, and Scatchard analyses demonstrate that both UTI-BP(40) and UTI-BP(45) bind (125)I-UTI. |
T6 | 958-1086 | Sentence | denotes | A deglycosylated form of UTI (NG-UTI), from which the chondroitin-sulfate side chain has been removed, binds only to UTI-BP(40). |
T7 | 1087-1306 | Sentence | denotes | Additional experiments, using various reagents to block binding of (125)I-UTI and NG-UTI to the UTI-BP(40) and UTI-BP(45) confirm that the chondroitin sulfate side chain of UTI is required for its binding to UTI-BP(45). |
T8 | 1307-1497 | Sentence | denotes | Analysis of binding of (125)I-UTI and NG-UTI to the cells suggests that low affinity binding sites are the UTI-BP(40) (which can bind NG-UTI), and the high affinity sites are the UTI-BP(45). |
T9 | 1498-1682 | Sentence | denotes | In addition, UTI-induced suppression of phorbol ester stimulated up-regulation of uPA is inhibited by reagents that were shown to prevent binding of UTI to the 40- and 45-kDa proteins. |
T10 | 1683-1767 | Sentence | denotes | We conclude that UTI must bind to both of the UTI-BPs to suppress uPA up-regulation. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-143 | Sentence | denotes | Characterization of binding properties of urinary trypsin inhibitor to cell-associated binding sites on human chondrosarcoma cell line HCS-2/8. |
T2 | 144-383 | Sentence | denotes | Urinary trypsin inhibitor (UTI) forms membrane complexes with UTI-binding proteins (UTI-BPs) and initiates modulation of urokinase-type plasminogen activator (uPA) expression, which results in UTI-mediated suppression of cell invasiveness. |
T3 | 384-731 | Sentence | denotes | It has been established that suppression of uPA expression and invasiveness by UTI is mediated through inhibition of protein kinase C-dependent signaling pathways and that human chondrosarcoma cell line HCS-2/8 expresses two types of UTI-BPs; a 40-kDa UTI-BP (UTI-BP(40)), which is identical to link protein (LP), and a 45-kDa UTI-BP (UTI-BP(45)). |
T4 | 732-810 | Sentence | denotes | Here we characterize binding properties of UTI-BPs.UTI complexes in the cells. |
T5 | 811-957 | Sentence | denotes | In vitro ligand blot, cell binding and competition assays, and Scatchard analyses demonstrate that both UTI-BP(40) and UTI-BP(45) bind (125)I-UTI. |
T6 | 958-1086 | Sentence | denotes | A deglycosylated form of UTI (NG-UTI), from which the chondroitin-sulfate side chain has been removed, binds only to UTI-BP(40). |
T7 | 1087-1306 | Sentence | denotes | Additional experiments, using various reagents to block binding of (125)I-UTI and NG-UTI to the UTI-BP(40) and UTI-BP(45) confirm that the chondroitin sulfate side chain of UTI is required for its binding to UTI-BP(45). |
T8 | 1307-1497 | Sentence | denotes | Analysis of binding of (125)I-UTI and NG-UTI to the cells suggests that low affinity binding sites are the UTI-BP(40) (which can bind NG-UTI), and the high affinity sites are the UTI-BP(45). |
T9 | 1498-1682 | Sentence | denotes | In addition, UTI-induced suppression of phorbol ester stimulated up-regulation of uPA is inhibited by reagents that were shown to prevent binding of UTI to the 40- and 45-kDa proteins. |
T10 | 1683-1767 | Sentence | denotes | We conclude that UTI must bind to both of the UTI-BPs to suppress uPA up-regulation. |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 1012-1023 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
T2 | 1226-1237 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 110-124 | Disease | denotes | chondrosarcoma | MONDO:0008977 |
T2 | 562-576 | Disease | denotes | chondrosarcoma | MONDO:0008977 |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1012-1023 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
T2 | 1226-1237 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 104-109 | OrganismTaxon | denotes | human | 9606 |
T2 | 556-561 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 182-190 | Body_part | denotes | membrane | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 135-138 | Cell | denotes | HCS | http://purl.obolibrary.org/obo/CL:0000745 |
T2 | 232-235 | Cell | denotes | BPs | http://purl.obolibrary.org/obo/CL:0000748 |
T3 | 587-590 | Cell | denotes | HCS | http://purl.obolibrary.org/obo/CL:0000745 |
T4 | 622-625 | Cell | denotes | BPs | http://purl.obolibrary.org/obo/CL:0000748 |
T5 | 1733-1736 | Cell | denotes | BPs | http://purl.obolibrary.org/obo/CL:0000748 |